J. Kashanna et al. / Tetrahedron Letters 54 (2013) 1634–1637
1637
17. (a) Harutyunyan, S. R.; Hartog, T. D.; Geurts, K.; Minnaard, A. J.; Feringa, B. L.
Chem. Rev. 2008, 108, 2824–2852; (b) Gou, S.; Ye, Z.; Shi, L.; Qing, D.; Zhang,
W.; Wang, Y. Appl. Organomet. Chem. 2010, 24, 517–522; (c) Lopez, F.; Minnard,
A. J.; Feringa, B. L. Acc. Chem. Res. 2007, 40, 188–197.
In conclusion, we have established an efficient C–C coupling at
b-position of -methylene -lactone moiety of parthenin with ali-
phatic, aromatic, vinyl and allyl Grignard reagents using Cu(1)I and
(R)-BINOL as simple catalyst system without protecting the alcohol
moiety.
a
c
18. General experimental procedure for the preparation of b-alkylated parthenin
derivatives (3a–3i): Cu(I)I (10 mol %, 0.019 g) was taken in an oven-dried 25 ml
two necked RB. It is cooled to À78 °C and, (R)-BINOL (10 mol %, 0.028 g)
dissolve in dry toluene (5 mL) and vinyl magnesium bromide (0.458 mmol,
0.0595 g in THF) were added under nitrogen atmosphere, stirred for 5 min,—
Then parthenin (0.100 g, 0. 382 mmol in THF) was added and stirred for 4 h.
The reaction mixture was concentrated in vacuo and extracted with EtOAc
(3 Â 30 mL). The combined organic extracts were dried over Na2SO4 and
concentrated in vacuo. The residue on purification by column chromatography
(ethyl acetate/hexane, 40:60) afforded pure products.
Acknowledgments
The authors thank the CSIR and UGC New Delhi for the financial
assistance. We are also thankful to Dr. Biswanath Das for his expert
suggestions.
The spectral and analytical data of some representative products are given
below:
References and notes
13b-ethenyl-11,13-dihydroparthenin (3a).
IR: 3451, 2960, 2875, 1664, 1620, 1380, 1200 cmÀ1 1H NMR (200 MHz, CDCl3):
;
d 7.49 (1H, d, J = 6.0 Hz), 6.19 (1H, d, J = 6.0 Hz), 5.87–5.73 (1H, m), 5.19–5.09
(2H, dd), 4.91 (1H, d, J = 8.0 Hz), 2.80–2.70 (H, m), 2.55–2.27 (3H, m), 2.17–2.01
(3H, m), 1.68–1.59 (2H, m), 1.33 (3H, s), 1.13 (3H, d, J = 8.0 Hz); 13CNMR
(50 MHz, CDCl3): d 210.5, 178.9, 162.5, 134.0132.0, 118.5, 84.9, 78.8, 59.2, 47.8,
45.5, 40.6, 35.5, 30.4, 27.0, 18.6, 17.0; ESIMS: m/z 291 [M+H]+. Anal. calcd for
1. (a) Wakefield, B. J. Organomagnesium Methods in Organic Chemistry; Academic
press: San Diego, 1995; (b) Silverman, G. S.; Rakita, P. E. Hand Book of Grignard
Reagents; Marcel Dekker: New York, 1996; (c) Richey, H. G., Jr. Grignard
Reagents: New Development; Wiley: Chichester, 2000.
2. Reviews: (a) Lai, Y.-H. Synthesis 1981, 585–604; (b) Eish, J. J. Organometallics
2002, 21, 5439–5463; (c) Knochel, P.; Dohle, W.; Gommermann, N.; Kneisel, F.
F.; Kopp, T.; Sapountzis, I.; Vu, V. A. Angew. Chem., Int. Ed. 2003, 42, 4302–4320.
3. Inoue, A.; Shinokubo, H.; Oshima, K. I. Synth. Org. Chem. Jpn. 2003, 61, 25–36.
4. (a) Meyer, A. I.; Comins, D. L. Tetrahedron Lett. 1978, 19, 5179–5182; (b) Nahm,
S.; Weinreb, S. M. Tetrahedron Lett. 1981, 22, 3815–3818; (c) Mukaiyama, T.;
Araki, M.; Takei, H. J. Am. Chem. Soc. 1973, 95, 4763–4765.
5. Wang, X.-J.; Li, Z.; Xiufeng, S.; Xu, Y.; Dhileepkumar, K.; Chris, H. S. Org. Lett.
2005, 7, 5593–5595.
6. Kelly, B. G.; Gelheany, D. G. Tetrahedron Lett. 2002, 43, 887–890.
7. Dambrm, V.; Villieras, M.; Janvier, P.; Toupet, L.; Amri, H.; Lebreton, J.; Villieras,
J. Tetrahedron 2001, 57, 2155–2170.
8. Fernando, L.; Adriaan, J. M.; Feringa, B. L. Acc. Chem. Res. 2007, 40, 179–188.
9. (a) Kupchan, S. M.; Eakin, M. A.; Thomas, A. M. J. Med. Chem. 1971, 14. 1147-1052;
(b) Mew, D.; Balza, F.; Towers, G. H. N.; Levy, J. G. Planta Med. 1982, 45, 23–27.
10. Pieman, A. K.; Towers, G. H. N. Biochem. Syst. Ecol. 1983, 11, 321–327.
11. Pieman, A. K.; Schneider, E. F. Biochem. Syst. Ecol. 1983, 21, 307–314.
12. Hopper, M.; Kirby, G. C.; Kulkarni, M. M.; Kulkarni, S. N.; Nagasampagi, B. A.;
O’Neill, M. J.; Philipson, J. D.; Rojatkar, S. R.; Warhurs, D. C. Eur. J. Med. Chem.
1990, 25, 717–723.
13. Hu, J.-N.; Patel, R.; Li, B.; Garo, E.; Hough, G. W.; Goering, M. G.; Yoo, H.-D.;
O’Neil, J. M.; Fldrige, G. R. J. Nat. Prod. 2007, 70, 604–607.
14. (a) Kanchan, S. D. Curr. Sci. 1975, 44, 358–359; (b) Patil, T. M.; Hedge, B. A. Curr.
Sci. 1988, 57, 1178–1181; (c) Das, B.; Das, R. Allelopathy 1995, 57, 95–101.
15. Subhendu, D.; Saxena, D. B. Pest Manag. Sci. 2001, 57, 95–101.
16. Sharma, G. L.; Bhutani, K. K. Planta Med. 1988, 54, 120–123.
C17H22O4: C, 70.32; H, 7.58%; found: C, 70.18; H, 7.64.
13b-isopropyl-11,13-dihydroparthenin (3d).
IR: 3439, 2924, 2853, 1757, 1717, 1640, 1453; 1H NMR (200 MHz, CDCl3): d
7.55 (1H, d, J = 6.0 Hz), 6.14 (1H, d, J = 6.0 Hz), 4.87 (1H, d, J = 8.0 Hz), 2.71–2.60
(1H, m), 2.40–2.29 (1H, m), 2.20–2.05 (2H, m), 1.90–1.50 (6H, m), 1.31–1.20
(3H, m), 1.12 (3H, d, J = 8.0 Hz), 0.92 (6H, d, J = 7.0 Hz): 13CNMR (50 MHz,
CDCl3): d 208, 179.0, 158.2, 138, 84.9, 78.0, 69.1, 54.0. 47.3, 44.5, 41.0, 30.2,
28.4, 25.6, 24.2, 18.5, 17.0; ESIMS: m/z 307 [M+H]+. Anal. calcd for C18H26O4: C,
71.05; H, 8.49%; found: C, 70.93; H, 8.55.
13b-tetradecanyl-11,13-dihydroparthenin (3f).
IR: 3438, 2921, 2855, 1748, 1716, 1639, 1455; 1H NMR (200 MHz, CDCl3): d
7.46 (1H, d, J = 6.0 Hz), 6.2 (1H, d, J = 6.0 Hz), 4.90 (1H, d, J = 8.0 Hz), 2.77–2.70
(1H, m), 2.30–2.19 (3H, m,), 2.18–1.90 (3H, m), 1.5–1.25 (33H, m), 1.14 (3H, d,
J = 8.0 Hz): 13CNMR (50 MHz, CDCl3): d 209.2, 179.4, 161.0, 134.6, 83.9, 78.6,
59.4, 44.9, 42.0, 40.2, 30.1, 29.0, 27.8, 17.6, 18.5, 17.1; ESIMS: m/z 450 [M+H]+.
Anal. calc for C29H37O4: C, 77.50; H, 8.24%; found: C, 77.38; H, 8.30.
13b-phenyl-11,13-dihydroparthenin (3g).
IR: 3444, 2925, 2856, 1757, 1718, 1639, 1451; 1H NMR (200 MHz, CDCl3): d
7.47 (1H, d, J = 6.0 Hz), 7.30 (2H, d, J = 8.0 Hz), 7.25 (2H, d, J = 8.0 Hz), 7.20 (1H,
dd), 6.21 (1H, d, J = 6.0 Hz), 4.78 (1H, d, J = 8.0 Hz), 3.10–3.05(1H, m), 3.00–2.92
(2H, m), 2.85–2.81 (1H, m), 2.34–2.24 (1H, m), 2.06–1.88 (2H, m), 1.80–1.55
(2H, m), 1.34 (3H, s), 1.11 (3H, d, J = 8.0 Hz); 13CNMR (50 MHz, CDCl3): d 204.2,
187.1, 167, 142.1, 132.5, 130.0, 128.0, 127.2, 81.2, 78.2, 59.1, 50.1. 46.7, 41.6,
33.2, 31.9, 29.8, 19.1, 18.4; ESIMS: m/z 341 [M+H]+. Anal. calc for C21H24O4: C,
74.11; H, 7.05%; found: C, 73.99; H, 7.11.